Oxford Sciences Innovation Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 19
- Investments
- 142
- Portfolio
- 65
- Exits
- 6
Oxford Sciences Innovation General Information
Description
Founded in 2015, Oxford Sciences Innovation (OSI) is a venture capital firm based in Oxford, United Kingdom. The firm works with the University of Oxford to build science-based companies that are focusing on creating technologies that tackle the problems of the world. OSI prefers to invest in life science, artificial intelligence and software, healthcare, and deep technology to create companies taking on challenges like nuclear fusion, quantum computing, and developing treatments and cures for infectious diseases
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Impact Investing
University
Primary Office
- 46 Woodstock Road
- Oxford OX2 6HT
- England, United Kingdom
+44 01865 000000
Oxford Sciences Innovation Investments (142)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Theolytics | 07-Jan-2021 | Early Stage VC | 00.000 | Drug Discovery | Pre-Clinical Trials | |
| 000 0000000000 | 22-Dec-2020 | 0000 00000 | 00.000 | Drug Discovery | Pre-Clinical Trials | 000000 00000000 00.0 |
| 00000 000000000000 | 21-Dec-2020 | 00000 00000 | Electronic Equipment and Instruments | Generating Revenue | 000000 0000000 | |
| 000000 | 09-Dec-2020 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
| 00000 00000000000 | 20-Nov-2020 | 00000 00000 | 000.00 | Diagnostic Equipment | Startup | 000000 000000 00 |
| 000000 | 11-Nov-2020 | 00000 00000 | 000.00 | Other Healthcare Technology Systems | Generating Revenue | 000000 0000000 |
| 0000 0000000 | 09-Nov-2020 | 00000 00000 | 000.00 | Business/Productivity Software | Generating Revenue | 0000000 000000 |
| 00000 00000 000000 | 09-Oct-2020 | 00000 00000 | 000.00 | Energy Production | Startup | 0000000 0000000 |
| BibliU | 14-Sep-2020 | Later Stage VC | 0000 | Educational Software | Generating Revenue | 0000 00000-00000 |
| ORCA Computing | 21-Jul-2020 | Seed Round | 00.000 | Computers, Parts and Peripherals | Startup |
Oxford Sciences Innovation Exits (6)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Base Genomics | 26-Oct-2020 | Merger/Acquisition | 00000 |
| 00000000 | 09-Apr-2020 | 000000000000000000 | |
| 00.00 | 31-Mar-2020 | 000000000000000000 | |
| 000000 00000 | 12-Dec-2019 | 000000000000000000 | |
| Oxtex | 01-Oct-2019 | Bankruptcy: Liquidation | |
| iOx Therapeutics | Merger/Acquisition |
Oxford Sciences Innovation Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialOxford Sciences Innovation Team (43)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Alexis Dormandy | Chief Executive Officer | 0 | 0 | Oxford, United Kingdom | |
| James Wilkinson | Chief Financial Officer | 0 | 0 | 0 | Oxford, United Kingdom |
| Kate O'Brien | Principal & Head of Legal and Company Secretary | Oxford, United Kingdom | |||
| Matthew Arnold | Principal | 00 | 0 | 0 | Oxford, United Kingdom |
| Nick Dixon-Clegg | Principal | 00 | 0 | 0 | Oxford, United Kingdom |
Oxford Sciences Innovation Co-Investors (120)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Parkwalk Advisors | 15 | 0 |
|
|
|
| Oxford Investment Consultants | 00 | 00 |
|
|
|
| Oxford University Innovation | 0 | 0 | 0 |
|
|
| IP Group | 0 | 0 |
|
|
|
| University of Oxford | 0 | 0 |
|
|